The Current Ratio as of December 2025 (TTM) for Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) is 5.32

According to Hubei Jumpcan Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 5.32. This represents a change of 13.06% compared to the average of 4.71 of the last 4 quarters.

Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) Historical Current Ratio (quarterly & annually)

How has 600566.SS Current Ratio performed in the past?

The mean historical Current Ratio of Hubei Jumpcan Pharmaceutical Co., Ltd. over the last ten years is 2.88. The current 5.32 Current Ratio has changed 18.38% with respect to the historical average. Over the past ten years (40 quarters), 600566.SS's Current Ratio was at its highest in in the September 2025 quarter at 5.32. The Current Ratio was at its lowest in in the June 2017 quarter at 1.84.

Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hubei Jumpcan Pharmaceutical Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) Average Current Ratio

How has 600566.SS Current Ratio performed in the past?

The current Current Ratio of Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) Current Ratio vs. Peers

How is 600566.SS’s Current Ratio compared to its peers?

Hubei Jumpcan Pharmaceutical Co., Ltd.’s Current Ratio is greater than China National Medicines Corporation Ltd. (2.15), greater than Joincare Pharmaceutical Group Industry Co.,Ltd. (2.63), greater than Tasly Pharmaceutical Group Co., Ltd (3.82), greater than Jilin Aodong Pharmaceutical Group Co., Ltd. (2.14), less than Jiangsu Nhwa Pharmaceutical Co., Ltd. (7.29), greater than China Resources Double-Crane Pharmaceutical Co.,Ltd. (2.25), greater than ApicHope Pharmaceutical Co., Ltd (1.49), greater than Betta Pharmaceuticals Co., Ltd. (0.77), greater than Intco Medical Technology Co., Ltd. (1.34), greater than Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (2.81),

Build a custom stock screener for Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hubei Jumpcan Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hubei Jumpcan Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.